








































































3.3.2	 Study	Populations	of	the	Included	Studies .............................................. 84	
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Study Design Population/Participants Intervention Outcome Measure(s) Results Comments 
Peake	et	al.(126) 
 
Prospective randomised double 
blind control trial 
 
Inclusion criteria 
  age ≥ 18 years 
  invasive ventilation 
  expected to receive enteral 
nutrition for  ≥ 48 hours  
 
Exclusion criteria 
  received ≥ 12 hours nutrition 
  fluid restriction 










n = 112 
 1.0 kcal/ml n = 55 
   obese n = 7 
 1.5 kcal/ml n = 57 
   obese n = 14 
1.0 kcal Vs 1.5 kcal 
 
Duration: up to 10 days 
 
Protein delivered was the same 
in each arm 
 
IBW used in energy 
calculations 
 
Accounted for “incidental” 
calories provided by propofol 
and dextrose infusions. 
 
 
Daily calorie delivery (1°) 
 
Mortality (ICU, hospital, 28 










Increased caloric delivery in 
the 1.5 kcal/ml arm. 
 
Mortality - trend towards 90 
day mortality benefit 
 
ICU / hospital LoS - no 
difference 
VFD’s - no difference 
GI intolerance - no difference 
    GRV - no difference 
    Diarrhoea - no difference 
Insulin dose - no difference 
 
Obese subgroup 
Increased caloric delivery in 
the 1.5 kcal/ml arm. 
 
Mortality - no difference. 
 
ICU / hospital LoS - no 
difference 
VFDs - no difference 
GRV - no difference 
Intolerance - no difference 
Diarrhoea - no difference 
Insulin dose - no difference 
Subgroup data 
 
Feasibility, pilot study. 
  
 





Study Design Population/Participants Intervention Outcome Measure(s) Results Comments 
Petros	et	al.(233) 
 




  need for artificial nutrition for ≥ 3 days 
 
Exclusion criteria 
  malnutrition 
  age < 18 or > 80 
  pregnancy 
  active malignancy 
  re-admission 
  DNR in place 
  refusal 
  consented too late 
Medical ICU single centre 
 
July 08 - Dec 10 
 
n = 100 
 normo n = 54 
   obese n = 6 
 hypo n = 46 





Energy target derived from 
IC or Ireton-Jones formula 
using actual body weight 
 
Duration: up to 7 days 
 
Do not specifically mention 
calories derived from 
propofol, but account for 
“non-nutrition calories” 
 
Up to 30% of daily caloric 











  increased nosocomial 
infections 
 
  reduced insulin 
requirement 
 
  less diarrhoea  
 
Obese subgroup* 
Mortality - no difference 
 
Insulin requirement - no 
difference. 
Nosocomial infection - no 
difference 
Diarrhoea - no difference 
Intolerance - no difference 
ICU LoS - no difference 






study.   
 





In the obese 
subgroup, 7/12 
patients had IC 












































Age	(years)	 56.0	(48.5	–	67.0)	 59	(45	–	67)	 0.85	
Body	weight	(kg)	 111	(98.0	–	117.5)	 104	(97.8	–	125.8)	 0.97	
Body	mass	index	(kg/m2)	 41.5	(35.8	–	44.3)	 35.6	(33.5	–	41.1)	 0.41	
Ideal	body	weight	(kg)	 56.0	(53.7	–	60.2)	 65.1	(61.5	–	73.3)	 0.05	
APACHE	II	 15.5	(13.5	–	31.5)	 24	(18	–	34.3)	 0.39	
Diabetes	mellitus,	n(%)	 4	(57%)	 6	(42%)	 0.88	
APACHE	III	admission	category	 	 	 	
										Neurological	 4	 1	 0.05	
										Respiratory	 1	 3	 0.84	
										Cardiovascular	 0	 3	 0.50	
										Sepsis	 0	 4	 0.33	
										Gastro-intestinal	 1	 1	 0.79	













Age	(years)	 64	(56.5	-	71.75)	 67	(61	-	69.25	 0.93	
Actual	body	weight	(kg)	 95	(95.0	-	107.5)	 95	(95.0	-	129.3)	 1.0	
Body	mass	index	(kg/m2)	 33.8	(33.1	-	35.3)	 34.9	(34.0	-	40.6)	 0.81	
APACHE	II	 27	(25.5	-	34.3)	 27	(25.5	-	37.0)	 0.75	
Diabetes	mellitus	 3	 0	 0.18	
Admission	diagnosis	 	 	 	
										Sepsis	 2	 4	 0.56	
										Cardiac	failure	 1	 0	 1.0	
										Cardiac	arrest	 2	 0	 0.44	































































Mortality (any time point) Yes	 Yes	
Mortality (ICU) Yes	 No	
Mortality (30-day) Yes	(28-day)	 Yes	(28-day)	
Mortality (60-day) No	 No	
Mortality (90-day) Yes	 No	
ICU Length of stay Yes	 Yes	
Hospital length of stay Yes	 Yes	
Duration of mechanical 
ventilation 
Yes	 No	
Nitrogen balance No	 No	
Azotaemia No	 No	
Acute kidney injury No	 No	
Nosocomial infection No	 Yes	
Weight loss/change in BMI No	 No	
Gastrointestinal intolerance Yes	 Yes	







































































Targeted	calories	(kcal/kg*/day)	 19.9	(18.3	–	21.6)	 29.3	(20.6	–	33.3)	 0.17	
Targeted	EN	per	day	(kcal/day)	 1081	(1043.5	–	1173.5)	 1670	(1296.75	–	2299.0)	 0.05	




Energy	delivered	(kcal/kg*/day)	 19.9	(18.6	–	24.4)	 30.1	(22.3	–	36)	 0.01	




Aspirate	volume	(ml	per	24	hours)	 48	(35	–	102)	 168	(51.8	–	280.5)	 0.85	
Largest	aspirate	(ml)	 200	(165	–	262.5)	 150	(42.5	–	315)	 0.740	





PEAKE	et	al.	(cont’d)	 1.0	kcal/ml	 1.5	kcal/ml	 p	Value	
Diarrhoea		 2	(29)	 4	(29)	 0.61	
Required	insulin	 4	(57)	 8	(57)	 0.64	
Days	with	BGL	<	2.2	mmol/L	(days)	 0	(0)	 0	(0)	 N/A	
Mean	insulin	dose	(U)	 32	(24.5	–	52.2)	 69.1	(43.8	–	131.9)	 0.15	
Day	28	VFD	 22.4	(16.2	–	25.3)	 22.6	(0.9	–	25.2)	 0.88	
ICU	LoS	(days)	 7.7	(	6.0	–	10.6)	 7.5	(5.0	–	10.5)	 0.97	
Hospital	LoS	(days)	 9.1	(7.7	–	26.3)	 16.5	(12.8	–	20.3)	 0.25	
ICU	mortality	 1	(14%)	 2	(15%)^	 0.55	
Hospital	mortality	 1	(14%)	 2	(15%)^	 0.55	
28-day	mortality	 1	(14%)	 2	(15%)^	 0.55	
90-day	mortality	 1	(14%)	 2	(15%)^	 0.55	

















































































































































Estimated	energy	expenditure	(kcal/kg*/day)	 15.7	(14.4	-	19.8)	 17.7	(16.3	-	19.2)	 0.58	
Calories	delivered	(kcal/kg^/day)	 13.0	(11.4	-	18.6)	 8.8	(7.4	-	9.5)	 0.01	
Protein	delivered	(grams/kg^/day)	 0.40	(0.39	-	0.62)	 0.29	(0.25	-	0.33)	 0.05	
Insulin	requirement	(IU/day)	 84.0	(75.0	-	126.3)	 24.5	(15.1	-	65.0)	 0.07	
EN	intolerance	(days)	 1.0	(0.3	-	3.0)	 0	(0	-	1)	 1.0	
Diarrhoea	(Y/N)	 4	 3	 1.0	
Diarrhoea	(number	of	days)	 1	(0.25	-	3)	 0	(0	-	1)	 0.58	
Nosocomial	infection#	 0	(0	-	0)	 0	(0	-	0)	 1.0	
ICU	LoS	(days)	 22.0	(13.8	-	35.3)	 31.0	(28.8	-	41.8)	 0.17	
Hospital	LoS	(days)	 30.0	(25.5	-	57.3)	 41	(41.0	-	68.3)	 0.57	













































































































































































































































































































































































































































































































































































































Feeding the Critically Ill Obese Patient: A Systematic Review Protocol 
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Review question/objective 
The objective of this review is to identify the effectiveness of enteral nutritional 
regimens targeting protein and calorie delivery for the critically ill obese patient 
on morbidity and mortality. 
More specifically, the review question is: 
In the critically ill obese patient, what is the optimal enteral protein and calorie 
target that improves mortality and morbidity?  
The primary outcome of interest will be a composite measure of mortality 
measured at either intensive care unit (ICU) discharge or 60 days. 
Secondary outcomes of interest include other markers of morbidity and include: 
- ICU or hospital length of stay; 
- duration of mechanical ventilation or ventilator free days; 
- incidence of nosocomial infection; 
- renal injury; 
- azotemia (blood urea nitrogen); 
- nitrogen balance; 
- lean muscle loss, and; 




The World Health Organization (WHO) defines obesity as abnormal or 
excessive fat accumulation that may impair health, or, empirically, as a body 
mass index (BMI) ≥	 30 kg/m2.(1, 2) Twenty-eight percent of the Australian 
population is obese with the prevalence rising to 44% in rural areas, and there 
is evidence that rates of obesity are increasing.(3-5) The prevalence of obese 
patients in the intensive care largely mirrors that of the general population.(6, 7) 
There is concern, however, that this may also be rising. A recently published 
multi-center nutritional study of critically ill patients reported a mean BMI of 29 in 
their sample, suggesting that just under 50% of their intensive care population is 
obese.(8) It is inevitable, therefore, that the intensivist will care for the critically ill 
obese patient. 
Managing the critically ill obese patient is challenging, not least due to the co-
morbid disease states frequently associated with obesity, including diabetes 
mellitus, cardiovascular disease, dyslipidaemia, sleep disordered breathing and 
respiratory insufficiency, hepatic steatohepatitis, chronic kidney disease and 
hypertension.(7, 9-14) There is also evidence that metabolic processes differ in the 
obese patient, particularly in those with underlying insulin resistance, itself a 
marker of the metabolic syndrome, which may predispose to futile cycling, 
altered fuel utilization and protein catabolism.(14-21) These issues are compounded 
by altered drug pharmacokinetics, and the additional logistical issues 
associated with prophylactic, therapeutic and diagnostic interventions. 
It is entirely plausible that the altered metabolic processes observed in the 
obese intensify and compound the metabolic changes that occur during critical 
illness. The early phases of critical illness are characterized by an increase in 
energy expenditure, resulting in a catabolic state driven by the stress 
response.(22-24) Activation of the stress response involves up-regulation of the 
sympathetic nervous system and the release of pituitary hormones resulting in 
altered cortisol metabolism and elevated levels of endogenous 
catecholamines.(25-27) These produce a range of metabolic disturbances including 
stress hyperglycaemia, arising from both peripheral resistance to the effects of 
anabolic factors (predominantly insulin) and increased hepatic 
gluconeogenesis.(27, 28) Proteolysis is accelerated releasing amino acids that are 
thought to be important in supporting tissue repair, immune defense and the 
synthesis of acute phase reactants.(29, 30) There is also altered mobilization of fuel 
stores, futile cycling, and evidence of altered lipoprotein metabolism.(15, 20, 26, 31) In 
the short term this is likely to be an adaptive response, but with time and 
ongoing inflammation this becomes maladaptive with a concomitant risk of 
protein-calorie malnutrition, immunosuppression and wasting of functional 
muscle tissue resulting from protein catabolism and further compounded by 
disuse atrophy.(20, 27, 32) Muscle atrophy and ICU acquired weakness is complex 
and poorly understood, but it is postulated that the provision of calories and 
sufficient protein to avoid a negative nitrogen balance mitigates this process.(29) 
Avoiding lean muscle mass loss in the obese intuitively has substantial 




There is, in addition, evolving evidence that hormones derived from both the gut 
and adipose tissue are also involved in the response to stress and critical 
illness, and that adipose tissue in particular is not a benign tissue bed, but 
rather should be considered an endocrine organ.(18, 33-35) Some of these hormones 
are thought to be pro-inflammatory and some anti-inflammatory, however both 
the net result and clinical significance of these is yet to be fully elucidated.(18, 27, 33) 
The provision of adequate nutrition has become an integral component of 
supportive ICU care, but is complex.(13) There is ongoing debate within the critical 
care literature regarding the optimal route of delivery, the target dose, and the 
macronutrient components (proportion of protein and non-protein calories) of 
nutritional support.(13, 27) A number of studies have associated caloric deficit with 
morbidity and mortality, with the resultant assumption that prescribing sufficient 
calories to match energy expenditure will reduce morbidity and mortality, 
although the evidence base underpinning this assumption is limited to 
observational studies and small, randomized trials.(13, 36-42) 
There is research available that suggests hyper-caloric feeding or hyper-
alimentation, particularly of carbohydrates, may result in increased morbidity 
including hyperglycaemia, liver steatosis, respiratory insufficiency with 
prolonged duration of mechanical ventilation, re-feeding syndrome and immune 
suppression.(27, 43-48) But, the results from studies of hypo-caloric and eucaloric 
feeding regimens in critically ill patients are conflicting, independent of the 
added metabolic complexities observed in the critically ill obese patient.(8, 13, 40, 49) 
Notwithstanding the debate regarding the dose and components of nutritional 
therapy, there is consensus that nutrition should be provided, preferably via the 
enteral route, and preferably initiated early in the ICU admission.(27, 50) The enteral 
route is preferred for a variety of reasons, not the least of which is cost. In 
addition there is evidence to suggest the enteral route is associated with the 
maintenance of gut integrity, a reduction in bacterial translocation and infection 
rates, a reduction in the incidence of stress ulceration, attenuation of oxidative 
stress, release of incretins and other entero-hormones, and modulation of 
systemic immune responses.(20, 27, 50-55) Yet there is evidence that the initiation of 
enteral nutritional support for the obese critically ill patient is delayed.(56) The 
reasons for this remain obscure, but may be associated with the false 
assumption that every obese patient has nutritional reserves due to their 
adipose tissues, and can therefore withstand longer periods with no, or reduced 
nutritional support.(56) In fact obesity does not necessarily protect from 
malnutrition, particularly protein and micronutrient malnutrition.(7, 20, 57-61) It has been 
suggested by some authors that the malnutrition status of critically ill patients is 
a stronger predictor of mortality than BMI per se, and that, once malnutrition 
status is controlled for, the apparent protective effects of obesity observed in 
several epidemiological studies dissipate.(7, 62-71) This would be consistent with the 
large body of evidence that associates malnutrition (BMI < 20 kg/m2) with 
increased mortality, and has led some authors to postulate that the weight-
mortality relationship is U-shaped.(13, 72-80) This has proven difficult to demonstrate, 
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however, due to recognized confounding influences such as chronic co-
morbidities, baseline nutritional status and the nature of the presenting critical 
illness.(13) 
This has led to interest in nutritional regimens targeting alternative calorie and 
protein goals to protect the obese critically ill patient from complications arising 
from critical illness, and particularly protein catabolism. Although, of the three 
major nutritional organizations, the American Society of Parenteral and Enteral 
Nutrition (ASPEN) is the only professional organization to make specific 
recommendations about providing enteral nutritional support to the critically ill 
obese patient recommending a regimen targeting a hypo-caloric, high-protein 
goal.(20) It is thought that this regimen, in which 60 - 70% of caloric requirements 
are provided promotes steady weight loss, while providing sufficient protein to 
achieve a neutral, or slightly positive, nitrogen balance, mitigating lean muscle 
mass loss, and allowing for wound healing.(52) Targeting weight loss is proposed 
to improve insulin sensitivity, improve nursing care and reduce the risk of co-
morbidities, although how this occurs, and whether it can occur over the 
relatively short time frame of an intensive care admission (days to weeks) 
remains unclear.(52) 
Supporting the critically ill obese patient will become an increasingly important 
skill in the intensivist’s armamentarium, and enteral nutritional therapy forms a 
cornerstone of this support. Yet, neither the optimal total caloric goal nor the 
macronutrient components of a feeding regimen for the critically ill obese patient 
is evident. Although the suggestion that altering the macronutrient goals for this 
vulnerable group of patients appears to have a sound physiological basis, the 
level of evidence supporting this remains unclear, and there are no systematic 
reviews of this topic. The aim of this systematic review is to evaluate the 
literature to determine the best available evidence describing a nutritional 
strategy that targets energy and protein delivery to reduce morbidity and 
mortality for the obese patient who is critically ill. 
Inclusion criteria 
Types of participants 
This review will consider studies that include critically ill obese adult patients 
receiving enteral nutritional support at any stage during their ICU admission for 
a time period of greater than 72 hours. Studies eligible for retrieval will include 
intensive care patients in intensive care units or alternatively using a population 
of patients in which greater than or equal to 50% of trial participants required 
mechanical ventilation. In attempting to limit the search to studies involving 
critically ill patients in this way, it is acknowledged that there are differing criteria 
that determine ICU admission between countries determined in part by 
resources, in part by cultural differences and in part by the model of intensive 
care that predominates (closed versus open intensive care units). This is, 
however, a universal conundrum of critical care research in which there is often 
heterogeneity in admission diagnosis, severity of disease, metabolic 




Critically ill populations composed of both elective and emergency ICU 
admissions will be included, as will critically ill populations with a medical or 
surgical admission diagnosis. 
The WHO definition of obesity will be used in this review, this is to say a BMI ≥	
30 kg/m2, where BMI is body mass in kilograms divided by the square of body 
height in meters.(2, 82) 
Studies examining a pediatric population, or using parenteral routes of 
administration will be excluded. 
 
Types of intervention(s)/phenomena of interest 
This review will consider all studies that compare any feeding/nutritional 
regimens that specify a goal protein and calorie target directed at the obese 
critically ill patient. 
 
Types of outcomes 
Endpoints of interest in this review are chosen primarily for their importance in 
patient centered outcomes, while secondary endpoints are chosen as surrogate 
markers of morbidity. 
The primary outcome for this review is a composite mortality outcome (ICU, 60 
or 90 day mortality) where they can be identified in studies retrieved. 
Secondary outcomes sought that are thought important in patient centred 
outcomes include ICU and hospital length of stay, duration of mechanical 
ventilation or it’s corollary ventilator free days. Other secondary outcomes will 
include include nitrogen balance, azotemia (blood urea nitrogen), acute kidney 
injury, the incidence of nosocomial infection and insulin requirement. 
Nitrogen balance has been chosen as a surrogate marker of the adequacy of 
protein supplementation and is calculated using formulae allowing for protein 
intake and 24 hour urinary protein excretion.(83) Azotemia (serum urea) and renal 
injury using RIFLE criteria as markers of potential harm related to the inability to 
clear protein metabolites.(84) The incidence of nosocomial infection since an 
association between nutritional status and nosocomial infection incidence has 
been identified in a number of studies.(85) Finally, given the experimental findings 
that indicate high glucose concentrations have a range of negative effects, 
including increasing the production or expression (or both) of pro-inflammatory 
mediators, decreased chemotaxis and phagocytosis, alteration in leukocyte 
adherence, reduced release of reactive oxygen species from neutrophils and 
alterations in endothelial integrity, insulin requirement has been chosen as a 
surrogate marker of glycemic control. In addition, given the range of metabolic 
disturbances seen in the critically ill obese patient, glycemic control is arguably 




Types of studies 
Studies eligible for retrieval will include, in the first instance, randomized 
controlled studies. In the absence of randomized controlled trials, any study with 
a non-randomized control, quasi-experimental, controlled before and after, or 
cohort study (whether prospective or retrospective) design will be considered for 
inclusion in order to provide a sufficient evidence base to inform on the 
effectiveness of different feeding regimes targeting calories and protein in the 
critically ill obese patient. 
Search strategy 
The search strategy will involve a three step process. An initial limited search of 
PubMed and CINAHL will be undertaken, followed by analysis of keywords 
contained in the titles and abstracts, and of the index terms used to describe the 
article. A second search with all identified key words will be undertaken across 
PubMed, Embase, ProQuest Dissertations and Theses and conference papers 
index, CINAHL, PyschINFO, Cochrane Central Trials Register, Web of Science, 
Australian and New Zealand Clinical Trials Register, the EU Clinical Trials 
Register, WHO Clinical Trials Register and ClinicalTrials.gov. Only studies 
published in English will be eligible for retrieval, and there will be no date limits 
applied. Thirdly the reference list of all identified reports and articles will be 
searched for additional studies. 
Initial key words to be used will be; (“critically ill”	OR “intensive care”) AND 
(obese OR overweight) AND (nutrition OR diet OR feed*). 
Assessment of methodological quality 
Quantitative papers selected for retrieval will be assessed by two independent 
reviewers for methodological validity prior to inclusion in the review using 
standardized critical appraisal instruments from the Joanna Briggs Institute 
Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) 
which is found in Appendix I. Any disagreement will be resolved through 
discussion, or with a third reviewer. 
Data collection 
Quantitative data will be extracted from papers included in the review using the 
standardized data extraction tool from JBI-MAStARI (Appendix II). The data 
extracted will include specific details about the intervention(s), populations, 
study methods and outcomes of significance to the review question and specific 
objectives. 
Data synthesis 
Analysis will be conducted on all primary and secondary outcomes where 
possible. Quantitative data will, where possible, be pooled in a statistical meta-
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analysis using JBI-MAStARI. All results will be subject to double data entry. 
Effect sizes expressed as odds ratio (for categorical data) and weighted mean 
differences (for continuous data) and their 95% confidence intervals will be 
calculated for analysis. Given the anticipated degree of heterogeneity, it is 
expected that a random effects model will be used. Heterogeneity will be 
assessed statistically using the standard chi squared, and, given the expected 
level of heterogeneity a random effects model will be used. Where statistical 
pooling is not possible, the findings will be presented in narrative form. 
If there is sufficient data, further exploratory synthesis and sensitivity analysis 
performed on the basis of ICU admission type (medical versus surgical and 
emergent versus elective) will be carried out to explore anticipated 
heterogeneity across studies. These subgroups will be considered as there is 
evidence that admission type effects ICU mortality.(86) Furthermore, since it is 
possible that older patients paradoxically require more protein to achieve a 
neutral nitrogen balance, while having a lower glomerular filtration rate, a 
comparison of outcomes in a cohort of younger patients (< 60 years of age), 
compared to older patients (> 60 years of age) would be appropriate.(83) 
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PubMED obesity logic grid  
Obese critically ill nutrition 
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hypocaloric feeding 
obese [tiab] OR obesity [tiab] OR 
overweight [tiab]  OR bariatric* 
[tiab] OR adipos* [tiab] OR body 
composition [mh] OR body 
composition [tiab] OR body mass 
index [tiab] OR  BMI [tiab] OR body 
weights and measures [mh] 
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OR intensive care [tiab] 
OR ICU [tiab] OR intensive 
care unit [mh] 
 
nutritional sciences [mh] OR nutritional physiological 
phenomena [mh] OR nutrition requirements [mh] OR 
nutritional requirements [mh] OR nutritional therapy 
[mh] OR enteral nutrition [mh] OR feeding method [mh] 
OR dietary proteins [mh] OR diet [mh] OR caloric 
restriction [mh] OR energy intake [mh] OR diet, 
carbohydrate-restricted [mh] OR diet, reducing [mh] 
OR food [mh] OR feeding [tiab] OR nutrition [tiab] OR 
hypo-caloric [tiab] OR hypocaloric [tiab] OR high 
protein [tiab] OR permissive underfeeding [tiab] OR 
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DISKW(BMI) OR DISKW(adiposity) OR 
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CINAHL obesity logic grid  
obese critically ill nutrition 
OR  
hypocaloric feeding 
MH obesity OR MH “body weight 
changes” OR MH “bariatric patients” OR 
MH “body weights and measures” OR MH 
“fat free mass” OR TI obes* OR AB obes* 
OR TI bariatric OR AB bariatric OR TI BMI 
OR AB BMI OR TI adipos* OR AB adipos* 
MH “critically ill patients” OR MH 
“critical illness” OR MH “critical care” 
OR MH “intensive care units” OR TI 
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“critical ill*” OR AB “critical ill*” 
MH “nutritional support” OR MH 
“enteral nutrition” OR MH “nutritional 
physiology” OR MH nutrition OR TI 
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(MH obesity OR MH “body weight changes” OR MH “bariatric patients” 
OR MH “body weights and measures” OR MH “fat free mass” OR TI 
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OR TI ICU OR AB ICU OR TI “intensive care” OR AB “intensive care” 
OR TI “critical ill*” OR AB “critical ill*”) AND (MH “nutritional support” OR 
MH “enteral nutrition” OR MH “nutritional physiology” OR MH nutrition 
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obese AND intensive care OR obesity AND intensive care OR obese 
AND critical care OR obesity AND critical care OR bariatric AND 
intensive care OR bariatric AND critical care OR BMI AND intensive care 
OR BMI AND critical care OR body mass index AND intensive care OR 
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obese AND intensive care OR obesity AND intensive care OR obese 
AND critical care OR obesity AND critical care OR bariatric AND 
intensive care OR bariatric AND critical care OR BMI AND intensive care 
OR BMI AND critical care OR body mass index AND intensive care OR 
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1. Was the assignment to treatment groups truly random? 
Yes Method by which randomisation to treatment or control group was 
clearly described by the author(s), and the method is likely to 
produce true randomisation (ie: each patient has an equal 
probability of allocation to each arm). 
No Methods other than randomisation used to allocate patients to a 
nutritional regimen. 
Unclear General terms like “random” and “randomisation” used but the 
















2. Were participants blinded to treatment allocation? 
Yes Appropriate methods were employed to ensure that patients were 
blinded to which arm (control or experimental) that they had been 
allocated (subject blinding). 
No Patients were aware of which arm they had been allocated even 
though blinding may have been possible. 














3. Was allocation to treatment groups concealed from the allocator? 
Yes Appropriate method used to ensure that the allocator was unaware 
of the arm to which patients were being allocated (allocator 
blinding) AND a method employed to ensure that the allocator was 
likely to be unaware of the order in which patients were allocated to 
a study arm (allocation concealment). 
No The allocator was aware of which group patients were being 
assigned, or was likely to be able to determine which group a 
patient was likely to be allocated. 
Unclear Insufficient information to determine whether allocation blinding 













4. Were the outcomes of people who withdrew described & included in 
the analysis? 
Yes The withdrawal of patients reported and the reasons for the 
withdrawal described. 
Patients who withdrew from the study were analysed in the group 
to which they were originally allocated (intention to treat analysis), 
preferably with the inclusion of a Consort diagram.  
All patients were included in the final calculations including those 
patients who had withdrawn from the study regardless of whether 
their final outcomes were measured. 
No No explanation of patient withdrawals or the significance of these 
withdrawals. 
Patients had had withdrawn from the study group were not 
analysed in the groups to which they were originally allocated. 
Unclear Incomplete description of patient withdrawals. 
Numbers of withdrawn patients fail to match result figures.  














5. Were those assessing outcomes blind to the treatment allocation? 
Yes Researchers collecting data on outcome measure(s) were unaware 
of the treatment allocation (assessor blinding). 
No Researchers collecting data on outcome measure(s) were aware, 
or likely to be aware, the treatment allocation. 













6. Were the control and treatment groups comparable at entry? 
Yes At a minimum the following baseline data for the patients was 
reported, and groups were reasonably matched for these. 
• age. 
• sex. 




• severity of illness (APACHE or SOFA score). 
• co-morbid disease states (particularly diabetes mellitus). 
No No or minimal reporting of baseline data. 















7. Were groups treated identically other than for the named 
interventions? 
Yes Patients in each arm of the study were treated identically for all 
other aspects of their intensive care admission. 
No Patients in each arm of the study were (or were likely to have 
been) treated substantially differently as a result of the arm to 
which they were allocated. 














8. Were outcomes measured in the same way for all groups? 
Yes A clear description and definition of the outcome(s) was provided. 
A description of how the outcome(s) were measured or proposed 
to be measured spefically; 
• mortality: deaths at a pre-specific time point or days alive at a 
time point; 
• ICU length of stay: the time from admission to the ICU till ICU 
discharge; 
• hospital length of stay: the time from ICU discharge until 
hospital discharge; 
• duration of mechanical ventilation: days requiring invasive 
ventilation or days free of ventilation at a pre-specified time 
point; 
• nitrogen balance: urinary analysis of nitrogen excretion to 
allow calculation of nitrogen balance; 
• azotaemia: measures of serum urea in either 𝝻mol/L or mg/dL 
• acute kidney injury: measured by RIFLE criteria;(Bellomo, 
2004) 
• nosocomial infection: standardised definition such as that 
proposed by the Centre for Disease Control (CDC) and 
confirmed by a blinded third party such as a radiologist or 
microbiologist. 
• weight change: measured in kilograms or pounds from ICU 
admission to a pre-determined time point following ICU 
discharge. 
• gastro-intestinal intolerance: measured by high gastric 
residual volumes (> 250 ml), or diarrhoea (> 4 loose 
stools/day). 
• insulin requirement: in international units (IU) per hour or daily 
requirement (IU/day). 
The timing of outcome measure(s) is clearly articulated. 
No The description of what was measured, how it was measured or 
when it was measured is different in each group. 













9. Were outcomes measured in a reliable way? 
Yes All outcomes were measured using standard methods or 
instruments. 
Outcome measure(s) supported in the literature. 
Where instruments were used they have been validated 
independently. 
No Estimates or self reported outcomes reported. 
Incorrect, inappropriate or non-standard methods or instruments 
were used. 
The reliability and/or variability and/or validity of the method(s) 
used for measuring outcome were no reported. 
No training provided to data collectors. 















10. Was appropriate statistical analysis used? 
Yes Appropriate statistical methods were used, described and reported. 
Numbers of patients with missing data were reported and there 
was an adequate description of how this was dealt with in 
reporting. 
No Statistical methods were either not described or inappropriate 
methods were used. 
Missing patient data was either not reported or not accounted for. 
















Include Exclude Seek further information Possibly contains 
subgroup data 













Reviewer: 	 Date: 	
Title: 	 	 	




1. Is the sample representative of patients in the population as a whole? 
Yes The sample described is representative of obese intensive care 
populations, particularly with regard to 
• age 
• severity of illness (as measured by APACHE II, APACHE III 
or SOFA or similar scoring system) 
• mix of medical, surgical, trauma critically ill patients. 
No The sample is clearly not representative of a critically ill population. 
Or 
Is limited in its selection to a subspecialty of intensive care 
medicine (for example largely trauma, surgical, burns or medical 
patients). 
Unclear Insufficient information provided to assess the representativeness 















2. Are the patients at a similar point in the course of their critical illness. 
Yes Inclusion in the study has occurred during the patient’s ICU 
admission. 
No Inclusion has not occurred during the patient’s ICU admission. 
Unclear Insufficient information provided to assess the time point in the 














3. Has bias been minimised in relation to selection of cases and 
controls? 
Yes There is a clear description of how the groups were selected (such 
as a pre-defined cohort with clear follow up period and clear points 
of measurement). 
Sample sizes are articulated. 
No No description of how the groups were selected. 
The methodology introduces an unreasonable risk of systematic 
bias including that is not acknowledged and/or has had no attempt 
at controlling. 
Unclear Insufficient information provided to assess whether the risk of bias 














4. Are confounding factors identified and strategies to deal with them 
stated? 
Yes Potential confounding factor(s) have been identified, measured and 
a description provided of the possible impact of the compounding 
factor(s). 
Potential confounding factors include: 
• the use of supplement parenteral nutrition. 
• co-morbid disease states. 
• impact of malnutrition. 
• samples in which there is an over represented subtype of 
critically ill patient (eg: trauma, surgical, medical, burns). 
No No measurement of potential confounding factor(s). 
Unclear Insufficient information provided to assess for the identification and 














5. Were outcomes assessed using objective criteria? 
Yes All outcomes were measured using standard methods or 
instruments. 
Outcome measure(s) supported in the literature. 
Where instruments were used they have been validated 
independently. 
No Estimates or self reported outcomes reported. 
Incorrect, inappropriate or non-standard methods or instruments 
were used. 
The reliability and/or variability and/or validity of the method(s) 
used for measuring outcome were no reported. 
No training provided to data collectors. 















6. Was followup carried over a sufficient time period? 
Yes Follow up has occurred until at least hospital discharge or death, 
whichever is earlier. 
No Followup has not occurred until hospital discharge or death. 















7. Were the outcomes of people who withdrew described and included in 
the analysis? 
Yes Withdrawal of patients reported and the reasons for the withdrawal 
described. 
Patients who withdrew from the study were analysed in the group 
to which they were originally allocated (intention to treat analysis), 
preferably with the inclusion of a Consort diagram. 
All patients were included in the final calculations including those 
patients who had withdrawn from the study regardless of whether 
their final outcomes were measured. 
No No explanation of patient withdrawals or the significance of these 
withdrawals. 
Patients had had withdrawn from the study group were not 
analysed in the groups to which they were originally allocated. 
Unclear Incomplete description of patient withdrawals. 
Numbers of withdrawn patients fail to match result figures.  













8. Were outcomes measured in a reliable way? 
Yes A clear description and definition of the outcome(s) was provided. 
A description of how the outcome(s) were measured or proposed 
to be measured spefically; 
• mortality: deaths at a pre-specific time point or days alive at a 
time point; 
• ICU length of stay: the time from admission to the ICU till ICU 
discharge; 
• hospital length of stay: the time from ICU discharge until 
hospital discharge; 
• duration of mechanical ventilation: days requiring invasive 
ventilation or days free of ventilation at a pre-specified time 
point; 
• nitrogen balance: urinary analysis of nitrogen excretion to 
allow calculation of nitrogen balance; 
• azotaemia: measures of serum urea in either 𝝻mol/L or mg/dL 
• acute kidney injury: measured by RIFLE criteria;(Bellomo, 
2004) 
• nosocomial infection: standardised definition such as that 
proposed by the Centre for Disease Control (CDC) and 
confirmed by a blinded third party such as a radiologist or 
microbiologist. 
• weight change: measured in kilograms or pounds from ICU 
admission to a pre-determined time point following ICU 
discharge. 
• gastro-intestinal intolerance: measured by high gastric 
residual volumes (> 250 ml), or diarrhoea (> 4 loose 
stools/day). 
• insulin requirement: in international units (IU) per hour or daily 
requirement (IU/day). 
The timing of outcome measure(s) is clearly articulated. 
No Estimates reported. 
Incorrect, inappropriate or non-standard methods or instruments 
were used. 
The reliability and/or variability and/or validity of the method(s) 
used for measuring outcome were not reported. 

















9. Was appropriate statistical analysis used? 
Yes Appropriate statistical methods were used, described and reported. 
Numbers of patients with missing data were reported and there 
was an adequate description of how this was dealt with in 
reporting. 
No Statistical methods were either not described or inappropriate 
methods were used. 
Missing patient data was either not reported or not accounted for. 















Include Exclude Seek further information Possibly contains 
subgroup data 














Reviewer: 	 Date: 	
Title: 	 	 	




RCT  Quasi-RCT  Longitudinal  









Group A 	 Group B 	
	 	 	 	
 
Interventions 
Intervention A 	 	 	
	 	 	 	
Intervention B 	 	 	
	 	 	 	





















Outcome Intervention (     ) 
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Outcome Intervention (     ) 
number / total number 
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Peake SL, Davies AR, Deane AM, Lange K, Moran JL, O'Connor SN, et 
al. Use of a concentrated enteral nutrition solution to increase calorie 
delivery to critically ill patients: a randomized, double-blind, clinical 
trial. America Journal of Clinical Nutrition. 2014 Aug;100(2):616-25. 
 
Petros S, Horbach M, Seidel F, Weidhase L. Hypocaloric vs 
Normocaloric Nutrition in Critically Ill Patients: A Prospective 
Randomized Pilot Trial. JPEN Journal of parenteral and enteral 






Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral 




Komjathy CM. Aggressive versus traditional enteral nutrition prescription 
in medical intensive care unit patients [M.S.]. Ann Arbor: Rush 
University; 2010. 
      
 
Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha 
MH, et al. Permissive underfeeding and intensive insulin therapy in 
critically ill patients: a randomized controlled trial. Am J Clin Nutr. 
2011 Mar;93(3):569-77. 
and 
Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones 
G, et al. Permissive Underfeeding or Standard Enteral Feeding in 
Critically Ill Adults. N Engl J Med. 2015 Jun 18;372(25):2398-408. 





National Heart L, Blood Institute Acute Respiratory Distress Syndrome 
Clinical Trials N, Rice TW, Wheeler AP, Thompson BT, Steingrub J, 
et al. Initial trophic vs full enteral feeding in patients with acute lung 
injury: the EDEN randomized trial. JAMA. 2012 Feb 22;307(8):795-
803. 
 






Ulusoy H, Ozkan AR, Kucuk AO, Besir A. The effects of hypocaloric 
underfeeding in adult ICU patients. Clinical Nutrition. 2014;33:S29. 
 






Charles EJ, Petroze RT, Metzger R, Hranjec T, Rosenberger LH, Riccio 
LM, et al. Hypocaloric compared with eucaloric nutritional support and 
its effect on infection rates in a surgical intensive care unit: a 




Doig GS, Simpson F, Heighes PT, Bellomo R, Chesher D, Caterson ID, 
et al. Restricted versus continued standard caloric intake during the 
management of refeeding syndrome in critically ill adults: a 
randomised, parallel-group, multicentre, single-blind controlled trial. 
The Lancet Respiratory medicine. 2015 Dec;3(12):943-52. 
 
 
Rugeles SJ, Rueda JD, Diaz CE, Rosselli D. Hyperproteic hypocaloric 
enteral nutrition in the critically ill patient: A randomized controlled 
clinical trial. Indian Journal of Critical Care Medicine. 2013 
Nov;17(6):343-9. 
and 
Rugeles S, Villarraga-Angulo LG, Ariza-Gutierrez A, Chaverra-Kornerup 
S, Lasalvia P, Rosselli D. High-protein hypocaloric vs normocaloric 
enteral nutrition in critically ill patients: A randomized clinical trial. 










Genton L, Dupertuis YM, Romand JA, Simonet ML, Jolliet P, Huber O, et 
al. Higher calorie prescription improves nutrient delivery during the 
first 5 days of enteral nutrition. Clinical Nutrition. 2004,;23(3):307-15. 
 
Reason for exclusion: Ineligible population - did not include ICU 
patients.  Recruited hospitalised patients only. 
 
Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, et 
al. The relationship between nutritional intake and clinical outcomes in 
critically ill patients: results of an international multicenter 
observational study. Intensive Care Medicine. 2009 Oct;35(10):1728-
37. 
 
Reason for exclusion: Ineligible design – no intervention.  
Observational study with no intervention arm designed to describe 
current practice. 
 
Arabi YM, Haddad SH, Aldawood AS, Al-Dorzi HM, Tamim HM, Sakkijha 
M, et al. Permissive underfeeding versus target enteral feeding in 
adult critically ill patients (PermiT Trial): a study protocol of a 
multicenter randomized controlled trial. Trials. 2012;13:191, 
 
Reason for exclusion: Ineligible design – no intervention.  A priori 
study protocol only. 
 
Dickerson RN, Medling TL, Smith AC, Maish GO, 3rd, Croce MA, Minard 
G, et al. Hypocaloric, high-protein nutrition therapy in older vs 
younger critically ill patients with obesity. Journal of Parenteral and 
Enteral Nutrition. 2013 May-Jun;37(3):342-51. 
 
Reason for exclusion: Ineligible design – no intervention.  




Charles EJ, Petroze RT, Hranjec T, Metzger R, Rosenberger LH, 
Swenson B, et al. Hypocaloric versus eucaloric nutrition support and 
its effect on infection rates in a single-institution surgical ICU. Surgical 
Infections. 2013;14:S1. 
 
Reason for exclusion: Ineligible – duplicate study.  Conference 
abstract containing no data.  Subsequently published in 2014 and 




Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral 
tube feeding in critically ill obese patients. Nutrition. 2002 
Mar;18(3):241-6. 
 
Reason for exclusion:  Author contacted, but declined to provide 
clarification about details of study and declined to provide subgroup 
data.  There were, in addition, substantial methodological issues 
including retrospective design with very high risk of selection bias, 
non-blinded, non-randomised sample that was almost exclusively 
trauma patients and further complicated by the use of an outdated 
definition of obesity (>125% IBW). 
 
Question Number* 1 2 3 4 5 6 7 8 9 Total Include 
Dickerson, 2002 N Y N N Y Y# U Y N^ 4 N 
 
* JBI MAStARI Critical Appraisal Tool for Cohort (with control)/ Case Controlled Studies (Appendix 
3.1) 
Y – yes, meets criterion. 
N – no, does not meet criterion. 
U – unknown, unclear from text whether criterion met. 
N/A^ - retrospective cohort controlled study, no withdrawals. 
# Follow up was of appropriate length in the context of the time at which the study was undertaken.  
In the current climate of critical care research ICU mortality would no longer be an appropriate 
time frame. 
^ given small numbers and high likelihood of non-normal distribution, median (and IQR) 
complemented by non-parametric statistical tests should have been used rather than mean (and 




Komjathy CM. Aggressive versus traditional enteral nutrition prescription 
in medical intensive care unit patients [M.S.]. Ann Arbor: Rush 
University; 2010. 
 
Reason for exclusion: No longer had access to raw data.  Deleted 
five years after data collection as per local Institutional Review Board 
requirements. 
 
Question Number* 1 2 3 4 5 6 7 8 9 10 Total Include 
Komjathy, 2010 Y Y N Y Y Y U Y Y N/A 6 N 
 
* JBI MAStARI Critical Appraisal Tool for Cohort (with control)/ Case Controlled Studies (Appendix 
3.2) 
Y – yes, meets criterion. 
N – no, does not meet criterion. 
U – unknown, unclear from text whether criterion met. 
N/A^ retrospective cohort controlled study, no withdrawals. 
 
Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha 
MH, et al. Permissive underfeeding and intensive insulin therapy in 
critically ill patients: a randomized controlled trial. Am J Clin Nutr. 
2011 Mar;93(3):569-77. 
 
Reason for exclusion: Author declined to provide subgroup data.  
Following email correspondence the author declined to provide 
subgroup data on the basis that subgroups from their trial were 
currently being analysed and prepared for publication.  As such they 
were not prepared to provide access to any raw or additional 




1 2 3 4 5 6 7 8 9 10 Total Include 
Arabi, 2011 Y N Y Y U Y N Y Y Y 7 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
 
National Heart L, Blood Institute Acute Respiratory Distress Syndrome 
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Clinical Trials N, Rice TW, Wheeler AP, Thompson BT, Steingrub J, 
et al. Initial trophic vs full enteral feeding in patients with acute lung 
injury: the EDEN randomized trial. JAMA. 2012 Feb 22;307(8):795-
803. 
 
Reason for exclusion:  No response from author despite multiple 




1 2 3 4 5 6 7 8 9 10 Total Include 
Rice, 2013 1 U U 1 U 1 0 U 0 1 4 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
 
Rugeles SJ, Rueda JD, Diaz CE, Rosselli D. Hyperproteic hypocaloric 
enteral nutrition in the critically ill patient: A randomized controlled 
clinical trial. Indian Journal of Critical Care Medicine. 2013 
Nov;17(6):343-9. 
 





1 2 3 4 5 6 7 8 9 10 Total Included 
Rugeles, 2016 Y U Y N U Y Y Y Y Y 7 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
 
Ulusoy H, Ozkan AR, Kucuk AO, Besir A. The effects of hypocaloric 
underfeeding in adult ICU patients. Clinical Nutrition. 2014;33:S29. 
 
Reason for exclusion: Conference abstract – unable to contact 
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1 2 3 4 5 6 7 8 9 Total Include 
Ulusoy, 2014 U U Y U Y Y N/A^ N U 3 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Cohort (with control)/ Case Controlled Studies (Appendix 
3.2) 
Y – yes, meets criterion. 
N – no, does not meet criterion. 
U – unknown, unclear from text whether criterion met. 
N/A^ retrospective cohort controlled study, no withdrawals. 
 
Charles EJ, Petroze RT, Metzger R, Hranjec T, Rosenberger LH, Riccio 
LM, et al. Hypocaloric compared with eucaloric nutritional support and 
its effect on infection rates in a surgical intensive care unit: a 
randomized controlled trial. American Journal of Clinical Nutrition. 
2014 Nov;100(5):1337-43. 
 
Reason for exclusion: Author declined to provide subgroup data.  
Following email correspondence the author declined to provide 
subgroup data on the basis that subgroups from their trial were being 
analysed and prepared for publication.  As such they were not 
prepared to provide access to any raw or additional subgroup data 
until such time as this had occurred.  Data in the public domain (a 
conference presentation) was provided; however this contained 




1 2 3 4 5 6 7 8 9 10 Total Include 
Charles 2014 Y U Y Y U Y Y U N Y 6 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
 
Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones 
G, et al. Permissive Underfeeding or Standard Enteral Feeding in 




Reason for exclusion: Author declined to provide subgroup data.  
Following email correspondence the author declined to provide 
subgroup data on the basis that subgroups from their trial were being 
analysed and prepared for publication.  As such they were not 
prepared to provide access to any raw or additional subgroup data 




1 2 3 4 5 6 7 8 9 10 TOTAL Included 
Arabi, 2015 Y N Y Y U Y Y Y Y Y 8 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
 
Rugeles S, Villarraga-Angulo LG, Ariza-Gutierrez A, Chaverra-Kornerup 
S, Lasalvia P, Rosselli D. High-protein hypocaloric vs normocaloric 
enteral nutrition in critically ill patients: A randomized clinical trial. 
Journal of critical care. 2016 Oct;35:110-4. 
 





1 2 3 4 5 6 7 8 9 10 Total Included 
Rugeles, 2016 Y U Y N U Y Y Y Y Y 7 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
 
Doig GS, Simpson F, Heighes PT, Bellomo R, Chesher D, Caterson ID, 
et al. Restricted versus continued standard caloric intake during the 
management of refeeding syndrome in critically ill adults: a 
randomised, parallel-group, multicentre, single-blind controlled trial. 








1 2 3 4 5 6 7 8 9 10 Total Included 
Doig et al, 2015 Y N Y Y Y Y Y Y Y Y 9 Subgroup 
 
* JBI MAStARI Critical Appraisal Tool for Randomised Control / Pseudo-randomised Trial (Appendix 
3.1) 
Y – yes, meets criterion 
N – no, does not meet criterion 
U – unknown, unclear from text whether criterion met 
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